A Retrospective, National, Multicenter Study Evaluating the Impact of Ulipristal Acetate (Esmya®) on Infertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques (ART)
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- Acronyms NACRE
- 20 Mar 2018 Planned End Date changed from 28 Feb 2018 to 30 Apr 2018.
- 20 Mar 2018 Planned primary completion date changed from 28 Feb 2018 to 30 Apr 2018.
- 20 Mar 2018 Status changed from not yet recruiting to recruiting.